Article
Genetic testing in prostate cancer management: Considerations informing primary care.
CA: a cancer journal for clinicians - 1 Jul 2022
Giri Veda N, Morgan Todd M, Morris David S, Berchuck Jacob E, Hyatt Colette, Taplin Mary-Ellen
Abstract excerpt
Inherited genetic mutations can significantly increase the risk for prostate cancer (PC), may be associated with aggressive disease and poorer outcomes, and can have hereditary cancer implications for men and their families. Germline genetic testing (hereditary cancer genetic testing) is now strongly recommended for patients with advanced/metastatic PC, particularly given the impact on targeted therapy selection...
Topics
- Genetic Counseling
- Genetic Predisposition to Disease
- Genetic Testing
- Humans
- Male
- Primary Health Care
- Prostatic Neoplasms
